These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6405197)

  • 1. Effect of chemical modification of arginine and lysine residues of fibronectin on its antigenic and gelatin-binding activity.
    Vuento M; Stenman UH; Salonen E; Osterlund K; Kuusela P
    Mol Immunol; 1983 Feb; 20(2):149-53. PubMed ID: 6405197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzyme-linked immunoassay for direct measurement of the gelatin-binding capacity of human plasma fibronectin.
    Damas P; Adam A; Closset J; Calay G; Foidart JM; Lamy M; Foidart J; Mahieu P
    J Immunol Methods; 1986 Jul; 91(2):205-11. PubMed ID: 3734459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional methionines in the collagen/gelatin binding domain of plasma fibronectin: effects of chemical modification by chloramine T.
    Miles AM; Smith RL
    Biochemistry; 1993 Aug; 32(32):8168-78. PubMed ID: 8347617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin.
    Sakata N; Sasatomi Y; Ando S; Meng J; Imanaga Y; Uesugi N; Takebayashi S
    Connect Tissue Res; 2000; 41(2):117-29. PubMed ID: 10992158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential charged amino acids in the binding of fibronectin to gelatin.
    Vuento M; Salonen E; Osterlund K; Stenman UH
    Biochem J; 1982 Jan; 201(1):1-8. PubMed ID: 7082278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible unfolding of the gelatin-binding domain of fibronectin: structural stability in relation to function.
    Isaacs BS; Brew SA; Ingham KC
    Biochemistry; 1989 Jan; 28(2):842-50. PubMed ID: 2713351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical and ultrastructural mapping of the gelatin-binding and cell-attachment regions of human plasma fibronectin with monoclonal antibodies.
    Hasty DL; Courtney HS; Simpson WA; McDonald JA; Beachey EH
    J Cell Sci; 1986 Mar; 81():125-41. PubMed ID: 3525581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
    Smith RL; Griffin CA
    Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independence of reciprocal attachment sites on denatured collagen and fibronectin from antigenic sites, and binding of gelatin-based plasma substitutes to plasma fibronectin.
    Adelmann-Grill BC
    Coll Relat Res; 1981 Jul; 1(4):367 -75. PubMed ID: 6179705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical characterization of human plasma fibronectin.
    Vuento M; Salonen E; Salminen K; Pasanen M; Stenman UK
    Biochem J; 1980 Dec; 191(3):719-27. PubMed ID: 6456720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytically stabilizing fibronectin without compromising cell and gelatin binding activity.
    Zhang C; Ramanathan A; Karuri NW
    Biotechnol Prog; 2015; 31(1):277-88. PubMed ID: 25394993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a new kinetic assay for the quantitation of fibronectin gelatin-binding activity.
    Gelder FB; Brown ST; Moore CA
    J Lab Clin Med; 1985 Oct; 106(4):416-23. PubMed ID: 4045297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of the binding of fibronectin to gelatin reveals the presence of different binding interactions.
    Garcia-Pardo A; Gold LI
    Arch Biochem Biophys; 1993 Jul; 304(1):181-8. PubMed ID: 8323285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of arginine residues of lung galaptin and fibronectin. Effects on fibroblast binding.
    Powell JT
    Biochem J; 1985 Dec; 232(3):919-22. PubMed ID: 4091829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
    Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
    Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin glycosylation modulates fibroblast adhesion and spreading.
    Jones GE; Arumugham RG; Tanzer ML
    J Cell Biol; 1986 Nov; 103(5):1663-70. PubMed ID: 2946699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of succinylation of antibodies on their conformation and interaction with the antigen.
    Ali J; Younus H
    Biochemistry (Mosc); 2006 Dec; 71(12):1336-40. PubMed ID: 17223786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of critical catalytic residues of lysine, arginine, and tryptophan in human glucose phosphate isomerase.
    Lu HS; Talent JM; Gracy RW
    J Biol Chem; 1981 Jan; 256(2):785-92. PubMed ID: 6778875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible binding of a guinea-pig lymphokine to gelatin and fibrinogen: possible relationship of macrophage agglutination factor and fibronectin.
    Godfrey HP; Purohit A
    Immunology; 1982 Jul; 46(3):515-26. PubMed ID: 6807837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.